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Abstract Drug delivery technology is still a dynamically
developing field of medicine. The main direction in nan-
otechnology research (nanocarriers, nanovehicles, etc.) is
efficient drug delivery to target cells with simultaneous
drug reduction concentration. However, nanotechnology
trends in reducing the carrier sizes to several nanometers
limit the volume of the loaded substance and may pose a
danger of uncontrolled access into the cells. On the other
hand, nanoparticles larger than 200 nm in diameter have
difficulties to undergo rapid diffusional transport through
cell membranes. The main advantage of large nanoparticles
is higher drug encapsulation efficiency and the ability to
deliver a wider array of drugs. Our present study con-
tributes a new approach with large Tween 80 solid lipid
nanoparticles SLN (i.e., hydrodynamic GM-SLN—glyc-
erol monostearate, GM, as the lipid and ATO5-SLNs—
glyceryl palmitostearate, ATO5, as the lipid) with diame-
ters DH of 379.4 nm and 547 nm, respectively. They are
used as drug carriers alone and in combination with elec-
troporation (EP) induced by millisecond pulsed electric
fields. We evaluate if EP can support the transport of large
nanocarriers into cells. The study was performed with two
cell lines: human colon adenocarcinoma LoVo and hamster
ovarian fibroblastoid CHO-K1 with coumarin 6 (C6) as a
fluorescent marker for encapsulation. The biological safety
of the potential treatment procedure was evaluated with
cell viability after their exposure to nanoparticles and EP.
The EP efficacy was evaluated by FACS method. The
impact on intracellular structure organization of cytoskele-
ton was visualized by CLSM method with alpha-actin and
beta-tubulin. The obtained results indicate low cytotoxicity
of both carrier types, free and loaded with C6. The eval-
uation of cytoskeleton proteins indicated no intracellular
structure damage. The intracellular uptake and accumula-
tion show that SLNs do not support transport of C6 cou-
marin. Only application of electroporation improved the
transport of encapsulated and free C6 into both treated cell
lines.
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Introduction
One of the main objectives of nanomedicine technology is
the delivery of poorly soluble drugs and/or supporting
their bioavailability, improvement of drug targeting to the
target cells with simultaneously reduced toxicity of nor-
mal cells, and additional control of the location and the
rate of drug release. Currently, nanosized carriers up to
200 nm in diameter are selected for pharmaceutical and
medical applications. Small sizes of nanoparticles increase
the probability of their efficient transport into the cells.
However, intracellular delivery system may benefit from
various types of carriers, ranging in diameter from
30 nm to several micrometers. The main advantage of all
nanocarriers is their ability to provide separate chemical
environments, which can protect the loaded cargo from a
potential damage (Lamch et al. 2014; Szczepanowicz
et al. 2014; Lima et al. 2013; Puglia et al. 2014; Wissing
et al. 2004; Bazylin´ska et al. 2012, 2014b). Nanosized
carriers are currently regarded as one of the most promising
directions in pharmaceutical research. They allow encap-
sulation of a complex cargo and its selective delivery to
cells, enabled with a variety of carrier surface modifica-
tions (Lamch et al. 2014; Bazylin´ska et al. 2012, 2014a,
b; Paliwal et al. 2014; Tran et al. 2014; de Morais et al.
2014; Saadeh et al. 2014). Large nanoparticles have many
advantages but there is still a great challenge concerning
their effective delivery into targeted cells. New approa-
ches are being developed but new research in this field
is still required. Lai et al. (2007) suggested additional
coating of large nanoparticles to enable their rapid pen-
etration into physiological human mucus. So far there is
no method suitable for effective delivery of large carriers
or vesicles, thus enhancement of their intracellular trans-
port is needed. SLNs are considered the next generation
of delivery system, after liposomes. Positively charged
nanoparticles are advantageous in targeted drug delivery
with regard to negatively charged cell surface. However,
the research of liposomes showed that both positive and
negative charges could enhance the delivery of liposomes
to cells through adsorptive endocytosis and the extension
of the half-life clearance of liposomes from the blood.
The half-life clearance can take from a minute to hours
and the distribution to organs can be controlled in part by
changing the physical properties of nanoparticles, such as
size, charge, and fluidity. However, some authors indicate
that positively charged lipids are not approved by FDA
for clinical use (Makholf et al. 2011). Zeta potential of
liposomes or nanoparticles is an important factor for their
cytotoxicity, and in some cases, cationic charge is
demanded to increase the cytotoxicity (Liu et al.2012;
Mu¨ller et al. 2001).
In this study, solid lipid nanoparticles (SLNs) were
applied. SLNs are nanocarriers composed of a lipid which
is solid both at body and room temperatures, stabilized by a
suitable surfactant. Aqueous SLN dispersions are alterna-
tive colloidal systems to polymeric nanoparticles, lipo-
somes, and emulsions, exhibiting many advantages, such as
good stability, high drug payload, possibility of controlled
drug release and drug targeting, low production costs
(Mehnertet al. 2001). SLNs can be an alternative system to
emulsions, liposomes, microparticles, and their polymeric
derivatives. Lipid nanoparticles with a solid matrix have
been proposed for encapsulation of many substances, such
as chemotherapeutics (Wissing et al. 2004), fluorescent
dyes (Caldero´n-Colo´n et al. 2015), photosensitizers (Lima
et al. 2013), and chemical UV-filters (Puglia et al. 2014).
SLNs are considered to be the next generation delivery
system, after liposomes. Their most advantageous features
include the solid state of the particle matrix, the ability to
protect chemically unstable cargo against chemical
decomposition, and the ability to modulate drug release
(M}uller et al. 2000).
The work reported here extends our recent studies on
delivery of large nanocarriers with fluorescent cargo, their
fabrication and imaging, drug encapsulation, release pro-
files, and biological impact (Szczepanowicz et al. 2014;
Bazylin´ska et al. 2012; Bazylin´ska et al. 2014a, b; Lamch
et al. 2014). This research is focused mainly on the effects
of combination of large-type SLNs with electroporation
(EP) on molecular transport of a loaded substance into
normal and cancer cells. EP is induced with a pulsed
millisecond electric field applied either before or after the
addition of the nanocarriers into the solution with cells; in
which the first mode enables an additional effect of elec-
trophoresis. Such nanocarriers, combined with EP may lead
to more effective transport of multidrug component and its




Two biodegradable lipids were selected to prepare solid
lipid nanoparticles: glycerol monostearate (GM) with the
melting point at 58–59 C and glyceryl palmitostearate (so
called Precirol and denoted as ATO5) with the melting
point at 56 C. Both of them are recognized as Generally
Recommended as Safe (GRAS) and have precedents of use
in approved pharmaceutical products. Lipids for SLN
production were supplied as follows: GM from CRODA
Inc. and Precirol ATO5 from Gattefosse, S.A. (France).
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Tween 80 (T80), which was used as a non-ionic surfactant,
tetrahydrofuran (THF), and coumarin 6 (C6; 3-(20-ben-
zothiazolyl)-7-diethylaminocoumarin; structure shown in
Fig. 1) were purchased from Sigma-Aldrich. Water used
for all experiments was doubly distilled and purified by
means of a Millipore (Bedford, MA) Milli-Q purification
system.
Preparation of SLN Dispersions
SLN dispersion was obtained with the ultrasound tech-
nique, coupled with previous hot homogenization (Bazy-
lin´ska et al. 2014a, b). The total amount of lipid phase (GM
or ATO5) was kept constant in all lipid nanoparticle sus-
pensions (4 %, w/w). The lipid nanoparticles in suspension
were stabilized using 0.5 % (w/w) concentration of sur-
factant (T80). Coumarin 6 was used in a concentration of
1 % (w/w) with regard to the solid lipid matrix.
Coumarin 6 was dissolved in 0.5 ml of THF and added
to lipids. The mixture was left for a night to completely
evaporate organic solvent. The lipid with embedded drug
was melted by heating it at 5 C above the melting point of
the lipid. The aqueous phase (surfactant dissolved in water)
was heated to the same temperature as the lipid phase, then
added to molten lipid phase and homogenized together
(T25 basic Ultra Turrax, IKA, USA) for 10 min at
16,000 rpm. The coarse hot (o/w) emulsion thus obtained
was sonicated for 15 min at the temperature of 70 C. The
obtained suspension was cooled down to room temperature
in ice bath to obtain solid lipid nanoparticles (denoted as
GM-SLN and ATO5-SLN, see Table 1).
Particle Size and Zeta Potential
The size measurements of the studied lipid nanoparticles
were performed with dynamic light scattering (DLS), using
a Malvern Zetasizer Nano ZS (Malvern Instruments, UK).
The detection angle zetasizer is 173 in optically homo-
geneous square polystyrene cells. DLS yields the hydro-
dynamic diameter (DH), which is an intensity weighted
mean diameter of the bulk population, and the polydis-
persity index (PdI) as a measure of the width of the particle
size distribution. The results are given as the average of 3
measurements, each with 10 runs.
Zeta potential (f-potential) of the SLNs was determined
with the microelectrophoretic method, using a Malvern
Zetasizer Nano ZS apparatus. The applied field intensity
was 20 V/cm. Each value was obtained as the average of
three subsequent runs of the instrument, each with at least
20 measurements. All the measurements were performed at
25 C.
Shape and Morphology
The shape and morphology of the dry nanoparticles were
studied using scanning electron microscopy (SEM) and
atomic force microscopy (AFM). SEM measurements were
made using JEOL JSM-6610LV (Jeol, Japan) at operation
voltage of 16 keV. Before measurements, SLN dispersions
were mounted on metal stubs for 24 h, for drying.
AFM measurements were made using the Veeco
NanoScope Dimension V AFM with an RT ESP Veeco
tube scanner. The scanning speed was 0.5 Hz and a low-
resonance-frequency pyramidal silicon cantilever (res-
onating at 250–331 kHz) was employed at a constant force
of 20–80 N/m. Before observations, SLNs were allowed to
adsorb on a freshly cleaved mica surface for 24 h by dip-
ping it into the suspension. Then, the excess of substrate
was removed by rinsing the mica plates in double distilled
water for 1 min and drying at room temperature for 6 h.
Determining Entrapment Efficiency
The percentage of incorporated coumarin 6 in SLNs (en-
trapment efficiency) was determined using UV–Vis spec-
troscopy, after centrifugation of the aqueous dispersion
(isolation of the nanoparticles), using Eppendorf centrifuge
5804 (Netheler Hinz GmbH). The UV absorbance mea-
surements were performed using a Metertech SP8001
spectrophotometer with a 1-cm pathlength thermostated
quartz cell. The cargo concentration was calculated using
the calibration plot. All the measurements were performed
in triplicate.Fig. 1 Molecular structure of coumarin 6 (C6)
Table 1 Characteristics of coumarin 6-loaded solid lipid
nanoparticles
System DH (nm) PdI f (mV) EE (%)
GM-SLN 379.4 0.225 -27.4 98.68
ATO5-SLN 547.0 0.304 -22.1 98.54
DH hydrodynamic diameter, PdI polydispersity index, f zeta poten-
tial, EE encapsulation efficiency, GM-SLN SLNs with glycerol
monostearate (GM) used as the lipid, ATO5-SLN SLNs with glyceryl
palmitostearate (AT05) used as the lipid
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We determined the difference between the mass of C6
entrapped in SLNs and the unloaded C6, which was mea-
sured in the supernatant of the resulting nanoparticle dis-
persion after the centrifugation. The entrapment efficiency
(EE) could be calculated by the following Eq. 1:
EE ½% ¼
total amount of coumarin 6  amount of free coumarin 6
total amount of coumarin 6
 100:
ð1Þ
Differential Scanning Calorimetry (DSC)
Differential scanning calorimetry (DSC) was used to
characterize the thermal characteristic, especially the lipid
melting temperature. Experiments were performed with
Setaram 32 CS (SETARAM, France) at the heating rate of
5 C/min in the temperature range of 0–250 C. Samples
were weighed (5–10 mg) on standard 40 ll aluminum pans
and then sealed. An empty sealed pan was used as a ref-
erence. DSC measurements were performed with the lyo-
philized SLN. The onset temperature and melting point
(peak maximum) were calculated.
Cell Culture
The studies were performed on human colon adenocar-
cinoma (LoVo) and hamster ovarian fibroblastoid (CHO-
K1) cell lines. Both cell lines were purchased from
ATCC (American Type Culture Collection). CHO-K1
cells can be applied as a model for transport studies with
the pulsed electric field due to very low expression of
endogenous ion channels (Gamper et al. 2005). The cell
line was selected for the model study of drug transport.
Ovarian fibroblasts were grown in Ham’s F-12 K
(Kaighn’s modification) medium (Gibco, Poland) with
addition of 10 % fetal bovine serum (FBS, HyClone,
Poland) and antibiotics (streptomycin/penicillin; Sigma).
LoVo cells were derived from metastatic tissue charac-
terized as colorectal adenocarcinoma of Dukes’ type C,
grade IV (acc. ATCC general information). This classi-
fication means that distant metastases were present, with
the involvement of lymph nodes. Colon adenocarcinoma
cell line was grown in Ham’s F-12 medium (Gibco,
Poland) with addition of 10 % fetal bovine serum (FBS,
HyClone, Poland) and supplemented with antibiotics
(penicillin/streptomycin; Sigma). The cell lines were
cultured in plastic flasks of 25 or 75 cm2 (Nunc, Den-
mark), which were stored at 37 C and 5 % CO2 in an
incubator (Steri-Cult, Thermo Scientific, Alab, Poland).
For the experiments the cells were detached by
trypsinization (Trypsin 0.025 %; Sigma) and neutralized
by the cell culture medium.
Electroporation Protocol
Electroporation, applied on cells alone and with addition of
free or encapsulated Coumarin-6 (EP ? C6), was per-
formed using ECM 830 Square Wave Electroporation
System (BTX Harvard Apparatus, purchased from Syngen
Biotech, Poland). After trypsinization and centrifugation
(5 min, 1000 rpm) cells were counted ([cells den-
sity] = 3 9 106/ml) and resuspended in 200 ll of EP
buffer with low electrical conductivity of 0.12 S/m
(10 mM KH2PO4/K2HPO4, 1 mM MgCl2, 250 mM
sucrose, pH 7.4) (We _zgowiec et al. 2013). In case of C6
incubation, cells were suspended in EP buffer with free C6,
[C6] = 5 lM, C6 encapsulated in ATO5-SLN and GM-
SLN-based nanocarriers. Additionally, EP was performed
with empty nanocarriers. SLN concentration was adjusted
to C6 concentration. EP experiments were performed in
two modes: (1) cells were electroporated simultaneously
with SLNs; (2) SLNs were added to the cells after EP
(delay up to 30 s). In each case, the same volumes of EP
buffer and SLN suspension were maintained (ratio 1:1).
Cell suspension was pulsed in a cuvette with two aluminum
plate electrodes, applying electrical fields E(appl)=100




U(appl) = 40, 200 or 400 V; (electrical field), d_elec-
trode = 0.4 cm; (distance between electrodes in cuvette).
Five rectangular electrical pulses were delivered by
electroporator ECM 830 (BTX, Syngen Biotech Poland),
pulse duration of 1.5 ms and pulse train repetition fre-
quency of 1 Hz. Control cells were not permeabilized, only
incubated with EP buffer or with C6 in EP buffer. After
pulsation, before further experiments, the cells were left for
10 min at 37 C, centrifuged, resuspended in cell culture
medium, and proceeded for viability assay and CLSM
study for cells electroporated simultaneously with SLNs.
Cells in which SLNs were added after the EP process were
subsequently assessed by fluorescent microscopy and
FACS analysis.
FACS Analysis: PI and C6 Uptake
Flow cytometry analysis was performed for assessment of
the cell ability to internalize propidium iodide and encap-
sulated coumarin 6 into the CHO-K1 and LoVo cells. Cells
were detached with Trypsin–EDTA and subjected to EP
protocol described in Sect. 2.8. Immediately before EP,
propidium iodide (PI, P4170, Sigma) was applied to the
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cell suspension. Concentration of PI in cuvette for the EP
buffer was [PI] = 20 lM. After EP process, the solution of
SLNs with C6 was added to cell suspension. The concen-
tration of C6 in the final volume was [C6] = 5 lM (200 ll
of cells suspension ? 200 ll of SLNs suspension). Then
the cells were incubated for 10 min at 37 C in a humidi-
fied atmosphere containing 5 % CO2. Then cells were
washed in PBS and resuspended in 0.5 ml of PBS. Flow
cytometric analysis was performed on a FACSCalibur flow
cytometer (Becton–Dickinson). The fluorescence of PI was
measured with FL-1 detector, the fluorescent signal for
coumarin 6 was detected with FL-3 detector. Data analy-
sis was performed with CellQuest software (Becton–
Dickinson).
The Viability Assay (MTT)
The cellular mitochondrial activity was determined with
the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetra-
zolium bromide) assay. MTT assay was performed 24 h
after the end of experiments to evaluate cells mitochondrial
dehydrogenase activity (NADH) as a viability marker. The
cells viability assay was performed according to the man-
ufacturer’s protocol (In Vitro Toxicology Assay, Sigma).
The absorbance was measured at 570 nm using multiwell
plate reader (EnSpire Multimode Reader, Perkin Elmer,
Poland). Three samples per each experiment were pre-
pared. Additionally, each experiment was performed in 3
independent repetitions. Mean values and standard devia-
tions of all results were calculated. The final results were
expressed as the percentage of mitochondrial function
relative to untreated control cells. The results obtained
from viability assays were subjected to statistical analysis.
The significance of differences between the mean values of
different groups of cells was assessed with T-test, which
returns the probability associated with the Students t test,
carried out for each experiment individually and n C 6. In
the statistical estimations, the level of P B 0.05 (*) was
regarded as statistically significant.
Fluorescent Microscopy (FL) for the Evaluation
of C6 Uptake and Distribution
CHO-K1 and LoVo cells were prepared for fluorescent
studies. Cells were primarily harvested on cover slides and
different EP protocols were performed (EP alone, EP with
C6, and EP with encapsulated C6) using a Petri-dish
electrode. EP process was performed in the presence of
propidium iodide (20 lM in EP buffer as in the Sect. 2.8)
to evaluate EP efficiency. Then SLNs suspensions with C6
(5 lM) were added to the slides. Cells were incubated for
10 min in 37 C, then washed with PBS, fixed with 4 %
paraformaldehyde, and washed with PBS. Then, the slides
were mounted with Roth fluorescent mounting medium
containing DAPI (4,6-diamidino-2-phenylindole) for nuclei
staining. C6 in cells was observed using excitation wave-
length kexc = 485 nm and observed in kem = 503 nm;
DAPI with kexc = 350 nm and kem = 470 nm, PI with
kexc = 536 nm and kem = 617 nm. For imaging, Olympus
BX53 fluorescent microscope with X-Cite 120PC Q
adapter was used.
CLMS for the Evaluation of Cytoskeleton
and Intracellular C6 Distribution
CHO-K1 and LoVo cells were prepared for immunofluo-
rescence. For the observation 10 min after EP, cells were
primarily harvested on cover slides and EP protocols were
performed with the Petri pulser electrode and then cells
were fixed with 4 % paraformaldehyde (PFA) in PBS. For
visualization, 24 h after experiments (EP, EP with C6, and
EP with encapsulated C6) cells were grown on coverslips
for 24 h, then fixed with 4 % PFA in PBS, and perme-
abilized with 0.5 % Triton X-100 in PBS (v/v) for 5 min. at
room temperature. Then, they were blocked with 1 %
Bovine serum Albumin (BSA) in PBS (for 30 min. at room
temperature). PBS was used for all washing steps. The
following antibodies were used: primary antibody—mon-
oclonal anti-b-tubulin antibody produced in mouse (over-
night incubation at 4 C; 1:100; Sigma-Aldrich); secondary
antibody—donkey anti-mouse IgG Cy5 conjugated (for
60 min. at room temperature; 1:50; Jackson ImmunoRe-
search). For F-actin identification, Alexa 546-conjugated
phalloidin was used (at a concentration of 1 nM; Life
Technologies). DNA was stained with DAPI (Life Tech-
nologies, 4,6-diamidino-2-phenylindole; 0.57 lM). Cell
were mounted in fluorescence mounting medium (DAKO).
C6 in cells was excited with wavelength kexc = 473 nm
and detected with kem = 650 nm. For imaging, Olympus
FluoView FV1000 confocal laser scanning microscope
(Olympus) was used. The images were recorded with Plan-
Apochromat 60x oil-immersion objective. Additionally,
images were analyzed with ImageJ software (Interactive
3D Surface Plot). A two-dimensional graph of the pixels
intensities (fluorescence intensity) was analyzed along a
marked line, within a selected single cell in the image. The
line was performed on the selected single cell from each
CLSM picture.
Results
In our study, coumarin 6-loaded SLN dispersions were
fabricated by the ultrasound technique coupled with the
previous hot homogenization. This technique is wide-
spread, offers low cost, and low energy consumption, as
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well as easy handling (Wissing et al. 2004; Fathi et al.
2013).
Characterization of the C6-Loaded Solid Lipid
Nanoparticles
In Table 1, presented are values of hydrodynamic diameter
(DH), polydispersity index (PdI), hydrophobic cargo
entrapment efficiency (EE), and zeta potential (f) of the
obtained samples GM-SLN and ATO5-SLN. Accordingly,
it can be concluded that the SLN dispersions displayed an
average size of 380 nm of diameter for GM used as a lipid,
and 550 nm—for ATO5. Values of PdI were ca. 0.225
and 0.304 nm, respectively, proving quite monodisperse
nanoproducts. Lipid nanoparticles were negatively charged
on the surface, exhibiting the f potential above |20| mV,
which may suggest a reasonable stability of the nanopar-
ticles’ dispersions. Furthermore, the SEM and AFM images
of GM-SLN and ATO5-SLN (see Fig. 2) provided the sizes
of samples similar to the values obtained primarily by DLS
and indicated that the nanostructures assumed semi-
spherical shapes and they did not show any enhanced
aggregation.
The DSC thermograms of C6, pure lipids, and cou-
marin-loaded SLN powder are shown in Fig. 3. The studied
lipids—ATO5 and GM—showed well-defined endothermic
peaks, indicating pure crystalline structure. C6 showed an
exothermic sharp peak at the melting point of 207.44 C,
responsible for the crystalline nature of the cargo. The
peaks from the nanoparticles are broader and shallower
than those of pure lipids, which indicates their less ordered
crystalline structure. However, both systems showed a
single peak, which proved that C6 was completely encap-
sulated inside the lipid matrix (Fathi et al. 2013). The
melting point of ATO5 is 57.57 C, but when this lipid is
used for the preparation of nanoparticles this value
increases to 61.42 C, which is the result of the cargo
(Casadei et al. 2006). For the system with GM, used as the
lipid, these values are 59.46 and 61.10 C, respectively.
Lyophilized SLNs display a offset of the melting temper-
ature to higher temperatures as compared to that of the pure
lipid. Endothermic peaks of pure lipids correspond to their
melting points (Fig. 4).
Viability Assay
The effect of EP parameters on both cell lines is pre-
sented in Fig. 5a for CHO-K1 cells and in Fig. 5b for
LoVo cells. The most cytotoxic effect was observed after
24 h for EP at 1000 V/cm, for both cell lines but with
stronger effect on CHO-K1 cells. The influence of free
SLNs, SLNs with encapsulated coumarin 6, and EP—
alone and in combination with empty or loaded SLNs is
presented in Fig. 5c for CHO-K1 and Fig. 5d for LoVo
cells. All viability results were obtained for experiments
performed with pre-addition of free C6 and encapsulated
in SLNs. The C6 concentration of 5 lM, applied in our
experiments, is regarded as non-cytotoxic and can be used
as a fluorescent marker. Higher concentrations would
induce the cytotoxic effect leading to significant cell
destruction or even cell death (Chuang et al. 2007; Ma
et al. 2012). The EP parameters (500 V/cm; 5 imp. each
of 1.5 ms duration) for SLNs delivery were selected as
optimal and non-toxic according to our MTT results and
the available literature reports (Cˇemazˇar et al. 2002; Yu
et al. 2011; Zou et al. 2014; Huang et al. 2014). Our
results confirm the published data and indicate that no
significant cytotoxic effect was observed in the case of
both cell lines. The stimulative impact on proliferation
was observed for the CHO-K1 cells when pulsed electric
field was applied in the presence of the solid lipid
nanocarriers (Fig. 5a). Then, an increase of mitochondrial
activity was observed at the level of 50 %. However, in
LoVo cells free C6, either with EP or without it, induced
only ca. 10 % decrease of cellular viability. In the pres-
ence of ATO5-SLN and GM-SLN nanoparticles, even ca.
Fig. 2 SEM images of a GM-SLN, b ATO5-SLN
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20–30 % decrease of cellular viability was observed.
Empty ATO5-SLN, which were not accompanied by the
pulsed electric field, maintained cell viability at the con-
trol level.
PI and C6 Uptake: FACS Analysis
The fluocytometric analysis is presented in Fig. 5e–g. The
results for PI uptake are presented for experiments
Fig. 3 AFM images of a GM-SLN, b ATO5-SLN
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performed with pre-addition of PI or C6, immediately
before electroporation. However, the results for C6 in
SLNs are presented for experiments in which nanoparticles
were added after EP. The dot plots indicate quantitative
distribution of cells with PI and C6 (Fig.SI-1). The study of
EP parameters indicated that cells of both lines could
effectively incorporate PI after EP, particularly after EP at
500 and 1000 V/cm (Fig. 5e). The evaluation of free and
encapsulated C6 uptake by cells showed the increase of
fluorescent signal after EP at 100 V/cm in both cell lines,
but the highest fluorescent signal was observed for cells
treated with 1000 V/cm and C6 in ATO5-SLNs (Fig. 5f,
g).
Coumarin-6 Intracellular Distribution
The intracellular distribution determined by fluorescent
microscopy of free C6, encapsulated and combined with
EP in ovarian fibroblasts and colon adenocarcinoma cells is
presented in Fig. 6a–f. These results concern experiments
in which loaded nanoparticles or free C6 were added
immediately after EP. In both cell lines, we could observe
the highest number of cells stained with propidium iodide
after EP at 500 and 1000 V/cm. We could also observe that
for C6 encapsulated in SLNs (ATO5 and GM), the most
intense fluorescent signal was also induced at these
parameters. C6 in SLNs was distributed in the cytoplasm
and in some cases it could be observed that it was clinging
to cell membranes (Fig. 6c for CHO-K1 cells but in par-
ticular in LoVo cells Fig. 6e). Also in control cells treated
with free C6 (Fig. 6a, d), we could observe enhanced flu-
orescent signal after EP (500 V/cm). Our observations
indicated similar fluorescent signal of encapsulated C6 in
both cell lines, in particular, after EP with the electric field
at 500 V/cm. In both cases, with GM-SLN and ATO5-
SLN, we could observe the enhanced transport, a little less
efficient as in case of free C6.
The results showing intracellular distribution of C6
determined by CLSM after experiments, where nanoparti-
cles were added before EP are presented in Fig. 7a, b
10 min after treatment incubation, and in Fig. 7c, d 24 h
after treatment. Additional analysis of fluorescence inten-
sity was performed with Fiji software (Image J) and pre-
sented in Fig. 8a, b from samples fixed 10 min after
experiment and in Fig. 8c, d from samples fixed 24 h after
experiment.
The results obtained for CHO-K1 cells indicate that only
free C6 can be efficiently transported by EP inside the cells
(Figs. 7a, c, 8a, c). The fluorescent signal for C6 in ATO5
or GM nanoparticles remained at the level of the cells
autofluorescence. Only in the case of electroporated
GM ? C6 green fluorescence was observed in single
points (Fig. 7a). In case of LoVo cells, we could detect the
same weak level of fluorescence in non-electroporated
cells. After EP, we could observe the increased accumu-
lation of free C6, but it was weaker than in the case of
CHO-K1. After EP with C6 encapsulated in large ATO5
and GM nanoparticles, we could observe almost the same
level of fluorescence as in the case of free fluorescent
marker (Fig. 7b). These data are more evident in Fig. 7b,
where histograms present the fluorescent intensity in
selected cell. Our results indicate that SLNs alone are not
delivered into cells. Only after electroporation the intra-
cellular transport of SLNs could be detected.
Fig. 4 DSC profiles of the
melting process of C6, lipids,
and C6- loaded SLNs
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Cytoskeleton Evaluation: CLSM Study
The visualization of cytoskeleton proteins in ovarian
fibroblasts and colon adenocarcinoma cells is presented in
Fig.SI-2 A and B (electroporated) for CHO-K1 cells and in
Fig.SI-3 A and B for LoVo cells. The cytoskeleton visu-
alization, for C6 free and encapsulated in SLNs, is pre-
sented for experiments in which nanoparticles were added
before EP. The evaluation of actin and tubulin indicated
that normal cytoskeleton structure was observed in both
treated cell lines. Only in the case of electroporated CHO-
K1 cells with GM ? C6 (Fig.SI-2B) we could observe
some tubulin reorganization, in the form of small fragments
distributed through intercellular environment. The short
time of incubation (10 min) with free and encapsulated C6
did not affect shape and morphology of treated cells.
Discussion
The electropermeabilization technology can be effectively
applied in transport of molecules, such as chemothera-
peutics in electrochemotherapy (Mir et al. 1992, 2003,
2014; Sersa et al. 1998, 2008, 2009; Heller et al. 2002;
Cˇemazˇar et al. 1998a, 1998b; Kulbacka et al. 2014; Saczko
et al. 2014; Vasquez et al. 2014; Campana et al. 2014;
Yarmush et al. 2014; Cadossi et al. 2014; Miklavcic et al.
2014) or nucleic acids in gene therapy (Jaroszeski et al.
1995, 1999, 2000, 2004; Heller et al. 1996, 2001, 2005,
2010; Ugen and Heller 2003; Gillbert et al. 2002; Aihara
et al. 1998; Miyazaki and Aihara 2002; Rols et al. 1998;
Gibot and Rols 2015; Faurie et al. 2003; Orio et al. 2013;
Forde et al. 2014; Emr et al. 2014; Kalli et al. 2014; Gehl
2014; Takei 2014; Hu and Li 2014). In the case of
Fig. 5 Top row the effect of EP parameters on cell viability (MTT
test): a CHO-K1 cells; b LoVo cells. Middle row the viability of cells
after treatment with free C6, empty, and C6-loaded nanoparticles
(GM-SLN and ATO5-SLN); SLNs and free C6 added before EP:
c CHO-K1 cells, d LoVo cells. Bottom row FACS analysis, uptake of
PI and free C6, added before EP, and SLNs added post-EP: e CHO-
K1 and LoVo cells—dependency of PI uptake (percent of cells) on EP
parameters; f CHO-K1 cells—uptake of free and encapsulated C6
(fluorescence intensity); g LoVo cells—uptake of free and encapsu-
lated C6 (fluorescence intensity)
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electrochemotherapy, electropores appearing in the cell
membrane after application of the electric field enable
transport of small non-lipophilic drug molecules into the
cell. Larger molecules, such as nucleic acids, enter the cell
due to the cell membrane electropermeabilization, which
results from EP and more widespread lipid disorganization.
Their transport also needs the electrophoretic effect of the
electric field, possible due to the electrical charge of
nucleic acid particles (Kee et al. 2011; Mir 2014). Some
authors have already applied EP to support nanoparticles
transport. Ramos et al. (2002) applied EP for facilitated
delivery of the large lipid unilamellar vesicles (LUVs). The
authors presented that LUVs may undergo fusion with
electropermeabilized cells. Additionally, it was observed
that the uptake of LUVs increased with the number of
pulses and the amount of liposomes that were added to the
cell suspension. Henri et al. (2015) also experimented with
LUVs. It was shown that when LUVs were electrostatically
carried into contact with electropermeabilized cells by a
salt bridge, their content was delivered into the cytoplasm
of the electropermeabilized cells. The authors also proved
that pulsing cells in the presence of highly fusogenic empty
LUVs improved the viability of cells. Yu et al. (2011)
indicated that EP assisted metallic nanoparticle delivery.
The authors concluded that the silver nanoparticle delivery
rate was the most efficient with the EP parameters slightly
higher than those used in our research, i.e., 4 consecutive
rectangular pulses at 875 V/cm, 1 ms and 10 ms durations.
Fig. 6 The fluorescence microscopy analysis of C6 and PI uptake
together with DAPI staining indicating cells nuclei. Top row free C6
uptake (without EP and EP at 500 V/cm, C6 added before EP):
a CHO-K1 cells; b LoVo cells; Middle row C6-loaded into GM-
SLNs, nanoparticles added immediately post-EP (100, 500 and
1000 V/cm): c CHO-K1 cells; d LoVo cells; Bottom row C6-loaded
into ATO5-SLNs, nanoparticles added immediately post-EP (100,
500 and 1000 V/cm): e CHO-K1 cells; f LoVo cells
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It was also indicated that low temperature (0–4 C) was
necessary for improving the delivery efficiency of silver
nanoparticles. Similar parameters that were applied in the
present study were also used in the case of gold nanopar-
ticles; Huang et al. (2014) applied gold nanoparticles
enhanced by 625 V/cm (1 pulse) for polyplex delivery to
mammalian cells. Cˇemazˇar et al. (2002) demonstrated that
electric pulses of lower amplitude and longer duration
(600 V/cm, 5 ms) generated significantly better transfec-
tion efficiency of plasmid DNA in liposomes, in compar-
ison to electric pulses of higher amplitude and shorter
duration (1200 V/cm, 0.1 ms). Zu et al. (2014) subjected a
highly conductive solution of gold nanoparticles (AuNPs)
to electroporation. Using EP (475 V/cm and 10 ms) they
Fig. 7 The evaluation C6 distribution in the cells using CLSM
analysis. C6-loaded in nanoparticles (GM-SLN and ATO5-SLN)
added before EP at 500 V/cm (5 pulses, 1.5 ms each) or no
electroporation applied. Images obtained 10 min after the procedure:
a CHO-K1 cells and b LoVo cells; and images obtained 24 h after the
procedure: c CHO-K1 cells and d LoVo cells
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demonstrated the enhanced DNA delivery with simulta-
neously increased cellular viability of mammalian cells.
The results obtained by Kim et al. (2011) showed that,
compared to cationic nanoparticles, anionic nanoparticles
had a better potential as electro-mediated gene transporters
at a low gene concentration. The approach involving
electropermeabilization and nanoparticles delivery is still
novel. As it was proved by Colacino et al. (2014), not only
enhanced drug delivery may be expected from this new
method but additionally the increased cancer cell cyto-
toxicity. The authors demonstrated the potential applica-
tion of folic acid-conjugated cellulose nanocrystals in the
potentiation of irreversible EP-induced cell death in folate
receptor (FR)-positive cancers. Pre-incubation with FA-
conjugated nanostructures (CNC-FA) led to a significant
increase in cytotoxicity when followed by irreversible EP.
Negatively charged SLNs, applied alone, are not effec-
tive in drug delivery. Our study presents the potential of
Fig. 7 continued
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ATO5-SLN) added before EP at
500 V/cm (5 pulses, 1.5 ms
each) or no electroporation
applied. Images obtained
10 min after the procedure:
a CHO-K1 cells and b LoVo
cells; and images obtained 24 h
after the procedure: c CHO-K1
cells and in d LoVo cells
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applying EP to enhance the transport of drugs encapsulated
in large SLNs. In the study, we used two different cell
lines—ovarian fibroblast CHO-K1 cells with very low
expression of endogenous ion channels, and colon adeno-
carcinoma LoVo cells. Both types of the applied SLNs
were relatively large (ca. 380 nm and 550 nm in diameter)
and negatively charged. The results obtained from C6
uptake (FACS) and distribution (fluorescent microscopy)
indicated that the external electrical field effectively sup-
ported transport of C6 encapsulated in SLNs. The enhanced
drug delivery was observed when SLNs were added
directly after EP into the cell culture. The enhanced
transport with no cytotoxic effects was obtained with five
1.5 ms rectangular pulses and 500 V/cm in cancer and
normal cell lines. The observed enhancement in SLNs
transport into the LoVo cells, as an effect of electropora-
tion, indicates its potential anticancer applications. Similar
EP parameters (typically between 50 and 500 V/cm with
millisecond pulses) occurred effective with regard to
another barrier, such as a tissue (Davalos et al. 2005).
Additionally, some studies based on computer modeling
and simulations clearly showed that the effects of
nanosecond, megavolt-per-meter pulsed electric fields and
of low-voltage, millisecond pulses are very similar at the
membrane level (Delemotte et al. 2012). Our experiments
performed on cells electroporated with SLNs indicated the
stimulative effect on cellular viability, i.e., the increased
activity of mitochondrial dehydrogenase in particular in
CHO-K1, which was measured by MTT assay.
Some authors observed fusion or electrophoretic effects
in case of nanocarriers combined with electroporation
applied after the addition of nanocarriers into the cell
environment (Ramos et al. 2002; Henri et al. 2015). In our
study, cancer LoVo cells showed amplified fluorescent
signal in cellular cytoplasm after electroporation with
SLNs. This effect was most probably due to the cell
membrane electroporation, strengthened with the elec-
trophoretic effect. However, this effect was not as potent as
it was expected. The electrophoretic contribution of elec-
tric field in the experiments with pre-EP addition of SLNs
appeared inefficient in drug delivery in normal cells. It was
well visualized in CLSM study, where we could observe
adhesive bounding of SLNs into external CHO-K1 mem-
branes. However, our results raise the question on the
mechanisms underlying these observations. Due to the
large size of the carriers, application of the electric field
must have enhanced the electrophoretic effect on the
negatively charged carriers. This was observed in LoVo
cells. However, EP did not enhance the SLNs transport into
CHO-K1 cells. These varying sensitivities and cellular
responses may be due to different characteristics of the
cells. CHO-K1 cells have low expression of ion channels.
Additionally, some studies report that CHO-K1 cells do not
contain cytochrome P450 enzymes and cannot metabolize
chemicals in culture (Born et al. 2000; McGregor et al.
1991). Other studies have shown that external electric
fields could induce fusion of a wide variety of cell and
artificial membranes (Dimitrov et al. 1995). This fusion
effect was also observed in our studies on SLNs and it
could have additionally increased the internalization of C6
in the cancer cells. Table 2 presents the main effects
obtained with SLNs added either pre-EP or post-EP. As it
was observed, SLNs without EP were not able to get into
the cells. Our results show that electroporation performed
on suspension of cells with SLNs leads to unsealing of
SLNs membranes and final premature cargo release form
nanocarriers, which is unfavorable in drug delivery pro-
cess. EP performed before SLNs addition only causes
permeabilization of the cellular membranes and enables
safe delivery of the nanocarriers with their full cargo.
According to the presented data, we can conclude that in
case of large anionic SLNs post-electroporation addition of
the nanocarriers is optimal for efficient drug delivery.
Our results demonstrated that the application of SLNs
with the pulsed millisecond electric fields could enhance
intracellular transport of large nanoparticles into cancer
cells, such as LoVo, and it does not affect cells viability if the
carrier content is not cytotoxic. Significant improvement in
drug uptake can be achieved, using optimized nanoparticles
and electroporation. So far SLNs, used in our study, have
been the largest nanocapsules whose transport increased due
to the application of electroporation. This enhancement can
be effectively applied in drug delivery, especially in the case
when higher active drug volume is required.
Table 2 The summary of the observed effects on large, anionic SLNs in combination with electroporation
SLNs added post-EP SLNs added before EP SLNs without EP
Enhanced transport of SLNs with active cargo Fusion of SLNs and cells No drug delivery
Permeabilization of cellular membranes only Electrophoretic effect on anionic SLNs
Adhesive bounding of SLNs to external cell membranes
Unsealing of SLNs and premature release of cargo
SLN solid lipid nanoparticles, EP electroporation
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